White House Blocks FDA’s Power to Regulate Lab Tests
FDA staunchly opposes the change, arguing that such authority is critical during a public health emergency
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Incidence of COVID-19 Up for American Indians, Alaska Natives
Cumulative incidence 594 per 100,000 population compared with 169 per 100,000 for Whites
Disparities Seen in COVID-19 Hospitalizations in Racial/Ethnic Subgroups
Percentage of hospitalizations among Black patients exceeded percent in the state population
SARS-CoV-2 Nasopharyngeal Load Higher in Children Than Adults
Highest viral load seen in the first two days of symptoms in children with SARS-CoV-2 infection
Advisory Panel Rejects Nearly All Proposals for Fetal Tissue Research
Nearly two-thirds of the members of the panel are outspoken opponents of fetal tissue research
Honey Beats Usual Care for Upper Respiratory Tract Infections
Improvement observed in symptoms of URTI, especially for cough frequency and cough severity
Disparities Seen in COVID-19 Hot Spots for Racial, Ethnic Minority Groups
96.2 percent of 79 counties identified as hot spots have disproportionate number of cases among minorities
Poll: More Older Adults Using Telehealth During Pandemic
Comfort level with technology and telehealth visits increasing, but some concerns persist
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
More data are under review; the approval could still be issued in the near future
